Kiniksa Pharmaceuticals International, plc (KNSA) › Shareholders' EquityKiniksa Pharmaceuticals International, plc (KNSA) — Shareholders' EquityAnnual figures by period end, from SEC filings.2016-12-31: -$25.73M2017-12-31: -$89.71M2018-12-31: $279.27M2019-12-31: $225.42M2020-12-31: $311.94M2021-12-31: $185.04M2022-12-31: $396.15M2023-12-31: $438.84M2024-12-31: $438.44M2025-12-31: $567.61M$567.61M2016-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$567.61M+29.5%2026-02-24Balance as of period end2024-12-31$438.44M-0.1%2026-02-24Balance as of period end2023-12-31$438.84M+10.8%2026-02-24Balance as of period end2022-12-31$396.15M+114.1%2026-02-24Balance as of period end2021-12-31$185.04M-40.7%2025-02-25Balance as of period end2020-12-31$311.94M+38.4%2024-02-28Balance as of period end2019-12-31$225.42M-19.3%2023-03-02Balance as of period end2018-12-31$279.27M—2022-02-24Balance as of period end2017-12-31-$89.71M—2021-02-25Balance as of period end2016-12-31-$25.73M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)